Market Place
Upload your Marketing & Sales content on your company Virtual Booth, click HERE
X
Please Wait
Applying Filters...
01 Lonza Biologics Inc. (1)
01 Ofatumumab (1)
01 U.S.A (1)
11
PharmaCompass offers a list of Ofatumumab API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Ofatumumab manufacturer or Ofatumumab supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Ofatumumab manufacturer or Ofatumumab supplier.
PharmaCompass also assists you with knowing the Ofatumumab API Price utilized in the formulation of products. Ofatumumab API Price is not always fixed or binding as the Ofatumumab Price is obtained through a variety of data sources. The Ofatumumab Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A arzerra manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of arzerra, including repackagers and relabelers. The FDA regulates arzerra manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. arzerra API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A arzerra supplier is an individual or a company that provides arzerra active pharmaceutical ingredient (API) or arzerra finished formulations upon request. The arzerra suppliers may include arzerra API manufacturers, exporters, distributors and traders.
click here to find a list of arzerra suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The arzerra Drug Master File in Japan (arzerra JDMF) empowers arzerra API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the arzerra JDMF during the approval evaluation for pharmaceutical products. At the time of arzerra JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of arzerra suppliers with JDMF on PharmaCompass.
We have 1 companies offering arzerra
Get in contact with the supplier of your choice:
